Login to Your Account

Financings Roundup

Aiming for Comeback, Intercell Hopes to Pad Coffers with $52M

By Nuala Moran
Staff Writer

Wednesday, May 9, 2012
LONDON – Intercell AG is raising €40 million (US$52 million) in debt and equity as it continues work to repair the damage wreaked by the clinical failure of vaccines against traveler's diarrhea and Staphylococcus aureus.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription